Western blot assays disclosed that the protein levels of ATF3, ATF4, and NRF2 demonstrated no significant difference when RND1 was overexpressed or knocked down in GBM cells (Fig. 3E and Additional file 4: Fig. S4C, D). The gene discussed is ATF3; the disease is glioblastoma.